Status:

ACTIVE_NOT_RECRUITING

Molecular and Epidemiological Characteristics of Endometrial Cancer in Brazil

Lead Sponsor:

Latin American Cooperative Oncology Group

Collaborating Sponsors:

GlaxoSmithKline

Conditions:

Endometrial Cancer

Eligibility:

FEMALE

18+ years

Brief Summary

An evaluation of the molecular and epidemiological aspects of endometrial cancer in Brazil is necessary to understand the high frequency of advanced disease. A better understanding of the current situ...

Detailed Description

This is a retrospective observational cohort study. In this study, we will include patients diagnosed with endometrium cancer from January 2016 to December 2019 in participating sites and collect data...

Eligibility Criteria

Inclusion

  • Women ≥18 years
  • Histological diagnosis of endometrial carcinoma.
  • Diagnosis of endometrial cancer between January 2016 and December 2019.
  • FIGO (International Federation of Gynecology and Obstetrics, 2018) Stage I - IV.
  • Site and investigator with access to a medical record chart from which data can be abstracted.
  • Presence of a sample of tumor tissue (primary tumor or metastasis) available for biomarker testing.

Exclusion

  • Noninvasive endometrial cancer.
  • Patients with a history of concurrent or previously treated non-endometrial malignancies except for appropriately treated 1) non -metastatic non-melanoma skin cancer and/or 2) non-metastatic low-grade thyroid tumors and/or 3) in situ carcinomas, including cervix, colon, and skin.
  • Nonepithelial histology (leiomyosarcoma, adenosarcoma, endometrial stromal sarcoma, undifferentiated sarcoma, or other mesenchymal tumors.

Key Trial Info

Start Date :

November 27 2023

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 31 2025

Estimated Enrollment :

276 Patients enrolled

Trial Details

Trial ID

NCT06014580

Start Date

November 27 2023

End Date

December 31 2025

Last Update

March 7 2025

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

ICC - Instituto do Câncer do Ceará

Fortaleza, Ceará, Brazil, 60.430-230

2

Hospital Evangélico de Cachoeiro de Itapemirim - Centro de Pesquisas Clínicas em Oncologia (CPCO)

Cachoeiro de Itapemirim, Espírito Santo, Brazil, 29.308-065

3

Santa Casa de Misericórdia de Feira de Santana

Feira de Santana, Estado de Bahia, Brazil

4

Clinica Prognóstica - Centro de Pesquisa Clínica Onconeo

Campo Grande, Mato Grosso do Sul, Brazil, 79.002-061

Molecular and Epidemiological Characteristics of Endometrial Cancer in Brazil | DecenTrialz